MedPath

Cardio Training of Older Adults With Central Obesity

Not Applicable
Conditions
Visceral Obesity
Interventions
Other: 10-week aerobic exercise program
Registration Number
NCT03450655
Lead Sponsor
Region Västerbotten
Brief Summary

Given the increasing prevalence of obesity, there is an urgent need to find better strategies to promote physical activity in the community. The present study will invite 70-year-olds with central (abdominal) obesity to participate in a 10-week aerobic exercise program. Participants will be randomly assigned to one of two equally large groups. The first group will complete the exercise program in instructor-led groups. The second group will complete the program at home with the help of an on-line video.

Detailed Description

Central obesity means having a lot visceral fat, that is, fat located in the abdominal cavity. Visceral fat is a well-established risk factor for cardiovascular disease and all-cause mortality.

Participants will be recruited from the Healthy Ageing Initiative (HAI), an ongoing population-based study that invites all 70-year-olds in Umeå, Sweden, to a health examination. The exercise program will focus is on station-based aerobic exercises and resistance exercises, predominantly with participants' own body weight as resistance. The program is progressive, starting at a moderate pace so that participants learn to perform the exercises properly. The intensity will be aimed at 60-80% of maximal exhaustion, and each exercise bout will last 60 seconds with 20 seconds of rest between bouts. The program was developed by seniors in the bachelor's program in exercise physiology at Umeå University, Sweden.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Participated in the Healthy Ageing Initiative (a population-based intervention study in Umeå, Sweden)
  • Visceral adipose tissue mass >1 kg (women) or >2 kg (men)
Exclusion Criteria
  • Physical disability that affects ability to perform the exercises
  • Heart failure or severe degenerative condition (e.g. malignant cancer or multiple sclerosis)
  • Myocardial infarction or stroke in the past year
  • Heart condition that can worsen with aerobic exercise (e.g. angina)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention Group10-week aerobic exercise programWeeks 1-10: exercise program in group. Weeks 11-20: no intervention. Weeks 21-31: no intervention.
Control group10-week aerobic exercise programWeeks 1-10: no intervention. Weeks 11-20: no intervention. Weeks 21-31: exercise program at home.
Primary Outcome Measures
NameTimeMethod
Change in visceral adipose tissue mass0, 10, 20, and 31 weeks

Mass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA).

Secondary Outcome Measures
NameTimeMethod
Change in health-related quality of life0, 10, 20, and 31 weeks

As measured by RAND-36

Change in self-reported physical activity0, 10, 20, and 31 weeks

Assessed using IPAQ-SF

Change in concentration of inflammatory markers0, 10, 20, and 31 weeks
Change in body composition0, 10, 20, and 31 weeks

Mass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA)

Change in blood-lipid profile0, 10, 20, and 31 weeks
Change in Microbiota composition0, 10, 20, and 31 weeks

Fecal samples are taken and bacterial DNA is sequenced to determine bacterial composition

Change in dietary habits0, 10, 20, and 31 weeks

85 item food frequency questionnaire

Change in physical capacity0, 10, 20, and 31 weeks

Measured using Åstrands Submaximal Test, performed on an electrically braked ergometer bicycle

Change in Body Mass Index (kg/m^2)0, 10, 20, and 31 weeks
Change in blood pressure (mmHg)0, 10, 20, and 31 weeks

Taken after 15 min of rest

Change in fasting blood glucose0, 10, 20, and 31 weeks

Veinous blood samples taken after \> 4 h of fasting

Change in isometric muscle strength0, 10, 20, and 31 weeks

Measured in non-dominant hand with dynamometer (Jamar, Lafayette Instrument, USA). The better of two successive trials will be recorded.

Change in resting metabolic rate0, 10, 20, and 31 weeks

As measured by indirect calorimetry

Trial Locations

Locations (1)

Livsmedicin (LIFE)

🇸🇪

Umeå, Västerbotten, Sweden

© Copyright 2025. All Rights Reserved by MedPath